BDX vs CRBU · P/E 34, rev $21.84B vs rev $3.9M
Becton Dickinson and Company (BDX) versus Caribou Biosciences Inc (CRBU) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Caribou Biosciences Inc (CRBU) is a biotechnology company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported CRBU revenue for 2026-06-30 was $3.9M. Net income was -$49.4M. Revenue was up 62.5% from 2026-03-31 to 2026-06-30. CRBU currently screens at market cap $190.4M.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. CRBU currently screens at market cap $190.4M.
Not investment advice. Open the BDX and CRBU stock pages for the full models.
Not investment advice.